How The Investment Story Is Shifting For Artivion (AORT) After Recent Analyst And FDA Updates [Yahoo! Finance]
Artivion, Inc. (AORT)
Company Research
Source: Yahoo! Finance
Artivion's updated fair value estimate has shifted to $51.57 from $51.43, a small change that still matters if you are watching where analysts think the stock should land. This adjustment aligns with more constructive commentary from bullish analysts, who see a more attractive balance of risk and reward at current levels, while more cautious voices are trimming targets on execution and cost concerns. As you read on, you will see how these competing views shape the evolving narrative around Artivion and what it could mean for your own research. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Artivion. What Wall Street Has Been Saying ?? Bullish Takeaways Ladenburg, through analyst Jeffrey, has turned more constructive on Artivion. The firm upgraded the shares and signaled that current pricing looks more appealing relative to its view of the company's potential. The Ladenburg upgrade adds support to the upda
Show less
Read more
Impact Snapshot
Event Time:
AORT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AORT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AORT alerts
High impacting Artivion, Inc. news events
Weekly update
A roundup of the hottest topics
AORT
News
- 1 Stock Under $50 to Own for Decades and 2 We Avoid [Yahoo! Finance]Yahoo! Finance
- Artivion (AORT) was upgraded by LADENBURG THALM/SH SH from "neutral" to "buy". They now have a $42.00 price target on the stock.MarketBeat
- Artivion Secures FDA Approval for NEXUS Aortic Arch System [Yahoo! Finance]Yahoo! Finance
- Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know [Yahoo! Finance]Yahoo! Finance
- Artivion (AORT) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $58.00 price target on the stock.MarketBeat
AORT
Earnings
- 2/12/26 - Beat
AORT
Sec Filings
- 4/1/26 - Form ARS
- 4/1/26 - Form DEFA14A
- 4/1/26 - Form DEF
- AORT's page on the SEC website